The paper details the current and potential uses of this rapidly developing technology, and its benefits and risks.
It provides an introduction to AI and its uses in human medicine, small animal, farm and equine practice, radiology and veterinary education.
It also looks at the potential impact on the wellbeing and working life of veterinary teams.
Results from VetCT’s recent survey on the opinions of AI within the veterinary profession are included in the paper.
Julien Labruyère, Chief Innovation Officer at VetCT, said: “This is a crucial moment in the veterinary industry to ensure we have the knowledge and safeguards in place to apply AI safely, effectively and with confidence to support good clinical practice and ultimately, improve animal welfare.
"This white paper aims to provide a firm foundation for understanding AI and stimulate discussion on how it may impact both people and animals.”
The paper also calls for the development of industry-wide guidance, standards and regulations to safeguard veterinary teams and animal health and welfare as these tools are deployed.
Julien added: “AI development is accelerating rapidly, with global governments and industries racing to regulate to ensure the benefits outweigh the potential negative impacts of this far-reaching technology.
"It’s vital that opinion leaders, organisations and regulators from across the veterinary world come together and develop guardrails so we can have confidence that AI tools will benefit our teams and our patients.”
https://5345458.hs-sites.com/vetct-ai-white-paper
Nominations will remain open until 5pm on Tuesday 31 January 2023 and the elections will take place in March and April 2023.
VN Council and its members are responsible for all matters concerning veterinary nurse training, post-qualification awards and the registration of qualified veterinary nurses, as well as the joint RCVS and British Veterinary Nursing Association (BVNA) VN Futures project.
Matthew Rendle, Chair of VN Council and an elected member since 2016, said: “As the stature of veterinary nurses has grown over the years, so too has VN Council and the VN Education Committee, with members taking decisions on the accreditation of veterinary nursing education providers, new qualifications, matters relating to the registration of veterinary nurses, as well as having strategic oversight of the VN Futures project and its mission to ensure that veterinary nursing is a vibrant, rewarding and sustainable profession.
“As a member of VN Council you will have a great opportunity to travel around the UK meeting your fellow nurses and getting fresh perspectives on what it means to be a VN, with a particular highlight being welcoming new veterinary nurses to the profession through our many registration and graduation ceremonies.”
The full eligibility criteria, info and FAQs for vets who want to stand can be found at: www.rcvs.org.uk/vncouncil23
Prospective candidates for VN Council can contact Matthew Rendle for an informal conversation on what it means to be an RCVS Council member on: vncchair@rcvs.org.uk
There is also an agenda of previous VN Council meetings at www.rcvs.org.uk/who-we-are/vn-council/vn-council-meetings/ for those who want to see examples of the kind of business it conducts.
Polypropylene or plastic-based wipes, which have been industry standard due to their reliable nature and compatibility with biocidal active materials, are due to be banned in the UK, because they take up to 100 years to break down.
Byotrol says its new wipes are made using a plastic-free 100% biodegradable substrate that deteriorates 3 months after disposal.
The company adds that the new wipes are proven to destroy bacteria, yeast, enveloped viruses, and fungi on non-porous surfaces and are effective against animal-specific pathogens such as: Brucella canis, Streptococcus equi, Staphylococcus aureus, Salmonella typhimurium, Bordetella bronchiseptica, Coronaviruses, Feline Immunodeficiency Virus (FIV), and Microsporum canis and Trichophyton mentagrophytes
Jane Kiely, Head of Marketing at Byotrol said: “Launching the Anigene Professional Surface Disinfectant Wipes is the final step in removing plastic wet wipes from our portfolio and a significant milestone in Byotrol’s sustainability journey.
"We are proud to be at the forefront of sustainability in the veterinary industry, offering an effective and regulatory-compliant product range that meets the needs of our customers”
Byotrol will be on Stand F18 at the London Vet Show.
https://byotrol.com
A few examples of the products in J.A.K Marketing's 'ThinkGreen' portfolio include the Purfect Anaesorber, BAG’EMS biodegradable poop bags, Tick Twister products (made from recycled plastic) and Bamboo stick cotton buds.
The website also gives a snapshot of the sorts of things that J.A.K itself does to reduce its impact on the environment, including the use of environmentally-friendly brown paper and recycled cardboard boxes for packaging. The company has also switched to certified sustainable FSC paper for most of its printed marketing materials (including the master catalogue) and is working with courier companies who have targets in reducing CO2 emissions.
Managing Director, John Holland said: "J.A.K Marketing is committed to the protection and preservation of the world’s ecosystem. By undertaking our productivity and operations responsibly and sustainably, we recognise that reducing the environmental impact of our activities is very important. We will strive to achieve environmental excellence within the veterinary industry and will continue to work closely with our employees and commercial partners to establish and follow the principles of our ThinkGreen policy."
Sales Director, James Johnson said: "With growing interest towards the protection of the environment, we need to make it easier for veterinary practices to identify products where there is a benefit to the environment by simply switching to a like for like ‘greener’ alternative. As part of our long-term strategy, we are dedicated to growing this area of our business, welcoming feedback from the profession of how we can all work together to achieve this."
Those wanting to offer inspiration and feedback can do so on the form at the bottom of the ‘ThinkGreen’ page: www.jakmarketing.co.uk/thinkgreen.
The referral centre has invested in a new heart and lung machine, and an oxygen cage, and is expected to take its first patients in the autumn.
The service will be established and led by head of cardiac surgery Poppy Bristow (pictured right) and head of cardiology Anne Kurosawa, who have already performed this kind of surgery on more than 100 dogs to date.
DWR is also setting up its own blood transfusion service to collect blood from staff and clients’ pets to support the service.
The blood collected will also be used to support the practice’s emergency and critical care service and its planned dialysis programme.
Poppy said: “There are hardly any other centres in the world offering this type of surgery, especially with this level of expertise that comes from the collective team we have gathered at DWR.
“Mitral valve disease is the most common heart condition in dogs and sadly, many dogs die every year as there are very few options for treatment. To be able to offer surgery to more dogs and their owners is really exciting.
“DWR is the perfect environment for this pioneering programme, due to the state-of-the-art equipment and depth of expertise on hand to support this life-saving initiative.”
Rob Foale, clinical director at Dick White Referrals, added: “It’s a hugely significant step for us to be launching this service, drawing on Poppy’s expertise in this field.
“We’re also starting our own blood transfusion service to complement the launch, as the pandemic has led to a huge drop in pet blood donations.
“Any excess blood we collect will be donated to the national Pet Blood Bank charity, which supplies blood to veterinary practices across the UK and does a fantastic job.”
For more information, visit www.dickwhitereferrals.com.
Teleradiology company, VetCT, is calling for companies developing and deploying AI in the field of veterinary diagnostic imaging to impose the highest standards of self-regulation. In an AI position statement released on their website, the company highlights the opportunities and risks associated with the use of AI to interpret diagnostic images.
In the joint statement, company owners Victoria Johnson and Julien Labruyère (pictured right), said: “We strongly welcome the introduction of appropriately developed, tested and implemented AI tools into our profession, to provide solutions to improve resourcing and benefit animal welfare.
“There is a limited pool of veterinary radiologists and an ever-increasing need for expert interpretation of radiographs and more advanced diagnostic imaging modalities.
"This presents a huge opportunity for the development of AI and related technologies to better address demand, save time and potentially improve clinical knowledge and outcomes.
"However, it is important to note that, unlike human radiology, there is no official framework for the regulation, governance and quality control of AI tools in veterinary radiology.
"This means that there should be a very strong onus on companies and individuals to adhere to the highest standards of medical tool development when creating AI solutions.”
“If AI is released into veterinary practice without appropriate oversight or governance there is a significant risk of misleading results, misdiagnosis, and negative impacts on patient welfare.
"This, in turn, may undermine trust in AI and create a culture of hesitancy to adopt new technologies at a time when innovation is much needed to improve access to advanced care.”
The company is advocating for a series of self-regulatory measures to be applied by companies developing AI in order to safeguard both animal welfare and the liability of the veterinary surgeons using these tools in clinical practice.
The full position statement and a list of recommendations can be here: https://www.vet-ct.com/gb/our-services/ai-veterinary-radiology/
The survey of 76 vets and nurses, which was conducted by the company in September and October 2024, found that 43% believe that staff wellbeing could be improved within their practice.
It also found that 93% agreed it is important for staff wellbeing to be taken seriously (Ed's note: one wonders what the other 7% think).
The most common strategies were:
NVS, which also sells a range of natural calming products for animals including NVS Select Calming Chews, also asked veterinary professionals how often they encounter nervous or stressed animals.
The answer from 92% of respondents was, perhaps a little unsurprisingly, daily.
82% said they use medications and supplements to support nervous animals.
https://www.nvsweb.co.uk/products/big-chill/
https://www.nvsweb.co.uk/our-brands/select-from-nvs
Zoetis, which has a portfolio of drugs for companion animals, including Apoquel, Cerenia, Convenia, Cytopoint, Librela and Simparica, says it will be sharing knowledge with BVNA members via webinars, regional CPD events and the Veterinary Nursing Journal (VNJ), and supporting the 2024 BVNA Congress.
Zoetis says the educational aspect of the partnership was developed after its market research showed that 8 in 10 veterinary nurses were interested in CPD support on the topic of parasiticides.
Louise Longstaff, National Veterinary Manager - Companion Animal, at Zoetis, said: "Veterinary nurses, alongside veterinary care assistants, all play a key role in the ongoing health and welfare of clients’ pets and as the backbone of every practice, they are to be applauded for all that they do.
"We are delighted to be able to announce this new initiative so soon after Veterinary Nursing Awareness Month and are proudly looking forward to delivering to the extended needs of RVNs as a reflection of our recent market research.”
BVNA President Lyndsay Hughes said: “We are delighted to collaborate with Zoetis on this new initiative.
"This partnership fully aligns with our commitment to promote the vital work of veterinary nurses in upholding animal welfare, plus those in wider veterinary care roles.
"We look forward to working together to enhance our offering to BVNA members, across many of our educational activities as an association.”
Photo: BVNA
The multicentre observational study described 382 placements of catheters across 19 different institutions, recording the placement techniques and tracking resulting complications to determine the associated risk factors.
The majority of the data was collected by veterinary nurses across the country.
The risk factors identified included the number of insertion attempts, whether a second subsequent placement was required, the frequency that the catheter was flushed and if the flush solution was compound sodium lactate.
In addition to identifying the risk factors, the study also found that complications occurred in just over one-quarter of placements, with limb swelling and phlebitis being the most common (11.5%).
The second most common complication observed was PIVC dislodgement/patient interference (7.9%).
As a result of these findings, the researchers are calling for more vigilant monitoring of patients with a PIVC in situ, particularly if they have experienced any of the factors that increase their risk of complications.
Eleanor said: “PIVCs are placed every day in almost all veterinary practices, yet there is little evidence to inform how best to place and manage them.
"I am passionate about providing the best care for cats and dogs, and it was fantastic to work with like-minded nurses and vets who wanted to gather the evidence that we can use to improve the care of our patients.
"I look forward to continuing this area of research, and believe veterinary nurses are best placed to undertake this work as it is part our of daily working lives."
Dr Christopher Scudder, Senior Lecturer in Small Animal Internal Medicine at the Royal Veterinary College and senior author in the study, said: “The hope is that this study will stimulate more research about PIVCs, and that sufficient evidence will be developed to help reduce complications associated with these routinely placed devices.”
Reference
The expansion has increased the hospital's footprint by 30%, adding three new operating theatres, six new consult rooms and new feline facilities, including a cat-only waiting room, consult room and treatment area.
Hospital owner, IVC Evidensia said the expansion has been driven in part by the pet ownership boom of the last few years and increased demand for the hospital’s services.
To meet the demand, Vale has expanded its office space, adding desk space for a further 25 vets.
There are also new ultrasound and cardiology rooms, a new dental suite and enlarged prep and recovery areas.
The existing kennel area has doubled in size with the addition of nine new walk-in kennels, a bespoke isolation ward and secure outdoor runs.
Richard Artingstall, clinical director at Vale Referrals, said: “We’ve been working on this expansion for a long time and it’s incredible to see it complete.
"Our new and improved facilities mean we can give even more pets across the Southwest the gold standard treatment that they deserve and support our colleagues from neighbouring vet practices with extensive referral services.
"The feedback from pets and owners so far has been very rewarding to hear.”
The feedback from pets?
Really?
VetSurgeon.org contacted recent patient Dougal McDoggins for comment.
He said: "Woof."
www.valereferrals.co.uk.
APPA is an oral, patented, fixed-dose combination of two synthetic secondary metabolites of plant origin, apocynin and paenol.
Under the terms of the agreement, AKL’s unnamed partner will fund a study in dogs with naturally occurring OA. The study will compare the efficacy and efficacy duration of APPA with the current standard of care for treating canine OA: non-steroidal anti-inflammatory drugs.
David Miles, AKLRD CEO, said: “Just like humans, millions of dogs suffer intolerable pain and disability because of OA and the current treatments just aren’t as effective or as well tolerated as they need to be. We already know from previous canine studies that APPA reduces pain and has an excellent tolerability profile but this exciting new partnership will allow us to go one stage further and assess sustainability of response.”
The randomised study will assess pain and duration of response as the primary endpoint. Secondary endpoint assessment will include adverse events, quality of life, pharmacokinetics analysis and biomarkers that may enable potential identification of factors predictive of response at treatment onset, or that correlate with response magnitude.
Two separate studies on dogs have already been carried out by researchers at the University of Vienna. The first, an 11-week cross-over study of 32 canines diagnosed with established, naturally occurring OA, showed that APPA provides significant symptom relief in clinical canine OA1.
A follow-up, five-week study of 60 dogs with OA compared APPA to the standard of care drug, meloxicam. It concluded that daily oral administration of APPA was effective as a stand-alone alternative to NSAIDs in dogs with naturally occurring OA. Significant benefits were also seen for APPA over meloxicam in orthopaedic examination as well as in lameness and function scores2.
The results will inform the pivotal clinical trial design and AKL says its working assumption is that a 26-week field study would complete the regulatory requirements for commercialisation.
If the study and future testing is successful, AKL estimates that APPA would be well placed to capture a significant share of the global canine OA market, which is estimated to be worth $3billion by 20283.
References
The operation of the equipment is being overseen by Dr Rodney Ayl, a specialist in both medical and radiation oncology. He said: "The need for protection of personnel during preparation of cytotoxic drugs presents the most significant obstacle to the safe provision of chemotherapy, as most practices are not equipped with an appropriate biosafety cabinet. This is especially true when there is a high case-load of chemotherapy patients."
Dr Ayl says the dangers of repeatedly handling and administering cancer drugs can be severe. He added: “The likelihood of drug exposure must be taken into account when considering the safety of personnel who handle cytotoxic drugs.
"The cumulative toxicity to personnel that arises from repeated contact with these drugs can cause health problems in the nursing staff that are beyond those expected in the patient.
"The main routes of personnel exposure to cytotoxic drugs are by aerosolisation or by absorption through skin.
"Both types of exposure can occur when preparing drugs for administration. The act of withdrawing cytotoxic drug from the vial into a syringe is generally the step that presents personnel with the greatest potential for exposure to a high concentration of drug.
"Ideally, personnel are optimally protected from drug exposure, and patients are protected from contamination of the product, by the use of a laminar flow biosafety cabinet (BCS) during drug preparation, regardless of whether a closed delivery system is used.
"The Envair CytoFAST BSC has been designed to guarantee the product, personnel and environmental protection.
"It belongs to the latest generation of laminar airflow systems and is built to the highest quality to guarantee the strictest safety standards - and the safety of our people is paramount at Paragon."
The 2022 programme will include 17 education streams, covering the veterinary and nursing care of companion animals, together with a stream covering veterinary wellness, leadership and management-related topics.
Speakers include veterinary experts and leaders from around the world, and the expected 2,000+ delegates will be able to collect 14 hours of CPD over the two days.
The VET Festival will also offer a Wellness Hub offering things like yoga, movement and mindfulness sessions alongside the lectures.
There'll be a diverse commercial exhibition, with more than 60 leading veterinary suppliers, and all delegates will also have free admission to the VETFest Live Party Night.
Noel Fitzpatrick, Clinical Chair at Fitzpatrick Referrals, who launched VET Festival in 2015, said: “The last 18 months have been tough for everyone but particularly difficult for veterinary professionals, many of whom were already suffering with challenges to their well-being and mental health because of the pressures of their work.
"VET Festival is an oasis of time during which they can relax and rejuvenate themselves; experiencing continuing professional development that is uplifting and inclusive and enjoying social activities and companionship that will replenish their souls.”
Tickets for VET Festival can be bought here: https://www.vetfestival.co.uk/delegate-info/ticket-information
To raise the funds, CVS put customer and staff collection boxes in its small animal first opinion practices and referral hospitals.
Staff also held a number of fundraising events – including sponsored walks and dog shows, as well as hosting Pet Blood Bank donation days.
The money raised from the partnership will help go towards funding Pet Blood Bank’s work.
Last year the charity sent over 5,000 units of blood to vets across the UK.
Pet Blood Bank provides training for vets and nurses, and donations also help the charity to keep the cost of blood products as low as possible, and provide them free to veterinary charities.
Deputy Chief Executive of CVS Group, Ben Jacklin, said: “Pet Blood Bank is a vital charity doing crucial work within our profession.
"There is no doubt that the level of funds raised is down to the tireless commitment shown by our colleagues up and down the country.
"I’d also like to recognise the role our clients have also made - as without them we would never have reached such a great total.”
Managing Director of Pet Blood Bank, Katrina Wilkinson said: “This generous donation from CVS Group has been incredible to receive.
"We are a small charity so need all the support we can get, and CVS has truly delivered."
CVS has recently announced its next charity partner as Guide Dogs for the Blind.
The Association says it has produced the leaflet after seeing an increasing number of dogs diagnosed with clinical or subclinical infection, along with reports of its zoonotic impact.
The document outlines the most important considerations concerning B. canis including transmission, diagnosis, management, public health implications and legislative requirements.
It takes into consideration information available from relevant Government Departments.
BSAVA says the document is by no means exhaustive but is intended to provide useful information and signpost to further resources.
www.bsavalibrary.com/brucella_canis
Photo: Walker16/Wikipedia. CC BY-SA 4.0.
The route covers a distance of approximately 400 miles.
Oscar said: “My goals for the event are to raise awareness about mental health within the veterinary profession and demonstrate how being in the countryside can boost wellbeing. Along the way, I’m keen to fundraise as much as possible for Vetlife.
“Vetlife has done so much for the veterinary profession with regards to making mental health support more accessible.
"Having that knowledge that they are there personally provides a lot of comfort in what can sometimes be quite a lonely and isolating profession.”
Fellow cyclist and Vetlife trustee Danny Chambers said: “I know how painful it is to cycle up Cheddar Gorge in North Somerset, so I am in awe that Oscar is cycling a 400-mile route around that terrain to visit every vet practice in Somerset in 2 days.
"I’m sure in his brief visits to each practice he’ll get a warm welcome and some sustenance to help him along to his next pit stop!
"Thank you to Oscar for his enthusiasm and support.”
Oscar is inviting others in the veterinary community to join sections of the journey along the way.
For more information on how to get involved with the cycle, visit the Somervet Facebook group: https://www.facebook.com/groups/1930480070643515.
Donate to the fundraiser via the Somervet JustGiving page: https://www.justgiving.com/page/ride-somervet
Snowflake previously had a squamous cell carcinoma mass on the right lower eyelid, which was completely removed in 2018.
However, her owner noticed an abnormal growth in the left eye, and brought her back to the RVC.
On presentation, Snowflake was bright and in good body condition, weighing 71kg.
Both eyes were open and appeared comfortable and visual.
Ocular reflexes and responses were also present as expected and there was no evidence of recurrence of the squamous cell carcinoma on the lower right eyelid.
Snowflake was, however, diagnosed with mild cataracts in her right eye deemed unlikely to interfere with her vision.
In addition, the mass of her left third eyelid was nonpigmented and displayed a poorly defined mass-like lesion, with an irregular surface on the leading edge, appearing consistent with a squamous cell carcinoma.
The team, led by Dr Maria-Christine Fischer, Lecturer in Ophthalmology, Dr Sara Lawrence-Mills, Senior Clinical Training Fellow in Anaesthesia, and Dr Carolina Palacios Jimenez, Lecturer in Anaesthesia, decided to undertake surgery.
They removed the third eyelid under sedation and applied local anaesthetic blocks and topical tetracaine eye drops.
Cryotherapy was then applied to the wound edge as an adjunctive therapy.
The RVC says that to date, there are few publications detailing anaesthesia in reindeer and so this protocol was a novel approach to maintaining a safe level of sedation in a well-domesticated animal.
The College added that the use of these nerve blocks to facilitate ophthalmic surgery has not been reported before and is in the process of being published.
Snowflake’s third eyelid was submitted for histopathology, which confirmed the diagnosis of squamous cell carcinoma, which the team at the RVC was able to remove completely.
During the process, Snowflake’s daughter was with her so they both remained calm, and she has now made a full recovery and has enjoyed being reunited with her herd.
Maria-Christine said: “Snowflake had a cancerous mass on her third eye lid.
"Surgical removal of the third eyelid in a reindeer has not been reported before.
"We were pleased that we could perform the surgery with Snowflake under a standing sedation and with using local anaesthetics.
"As an ophthalmologist, I am committed to preserving vision so it’s rewarding that we were able to completely excise the tumour and did not have to remove the eyeball. It’s a very good outcome.
"I’m also pleased that Snowflake recovered quickly from the procedure, and we were able to share the protocol of the sedation and the local nerve blocks with other vets via a scientific publication.
"Sharing our knowledge will hopefully be beneficial for future ophthalmic surgeries in reindeer.”
* aka Mr Nick Dean.
Speakers include Dr. Cecilia Villaverde, Consultant at Expert Pet Nutrition and Dr. Aarti Kathrani, Senior Lecturer in Small Animal Internal Medicine at the Royal Veterinary College, and there'll be sessions on managing adverse food reactions, incorporating probiotics into clinical practice and acute gastrointestinal disease.
Attendees will also be able to explore strategies to build strong personal and professional client relationships, including how to initiate effective nutrition conversations and resolve potential conflicts.
On the subject of mental well-being, there'll be expert tips and tricks to help veterinary nurses maintain emotional resilience and thrive in their demanding roles.
https://www.vet-center.eu/eu/pro-plan-vet-nurse-symposium
The company says the return to a ‘new normal’ post-lockdown provides a significant opportunity for practices to apply a renewed focus to preventative healthcare, recommending parasiticides as a way to improve animal welfare and generate practice revenue, which is vital for economic recovery.
Caitrina Oakes, Vetoquinol Managing Director UK and Ireland, said: “With many pet owners spending more hours than ever with their pets during lockdown, companion animal parasiticides have never been more important – making Profender and Drontal highly relevant in the current environment.”
She added: “It’s a very challenging time for many veterinary practices as everyone adapts to the post-COVID world. I’m looking forward to seeing how the passion and ambition we bring to our brands helps Profender and Drontal to grow and helps us to better serve the needs of the veterinary community, both now and in the future.”
Up to date information on the brands and their distribution can be found on the Vetoquinol website, www.vetoquinol.co.uk, by calling 01280 814500, or practices can contact their Vetoquinol Territory Manager directly.
The new RUMA Companion Animal and Equine Group will initially focus on encouraging efforts to promote responsible antibiotic use.
Steve Howard, head of clinical services at the People’s Dispensary for Sick Animals and secretary general of the new group, said: "RUMA has spearheaded successful efforts to steward antibiotic use in farmed animals over the past five years, and we would like to see whether its principles can augment the considerable progress that’s already been made in the companion animal and equine sectors.
"The most notable of RUMA’s initiatives is the Targets Task Force, which has seen leading vets and farmers from each species working together with industry groups to develop meaningful goals for reducing, refining or replacing antibiotic use.
"Through establishing such proactive approaches towards antibiotic stewardship in companion animals and equines, we hope to optimise their health and welfare – as well as that of humans and the environment."
RUMA says that although total antibiotic sales are significantly lower for companion animals compared with the farming sector, even relatively low use can result in resistance to key medicines if good stewardship principles are not applied.
The collaboration will cover use of medicines in dogs, cats, rabbits, small mammals, exotic animals kept as pets, and equids. The aim is for the UK to lead the way in these sectors through evidence-based and measurable activities that will promote and enhance stewardship.
Gwyn Jones, chair of the new group (pictured right), said: "As a collaborative group we need to establish evidence-based protocols for reducing, replacing or refining antibiotic use in companion animals, to further help preserve and prolong the use of these vital tools for human and animal health.
“Efforts will be focused towards identifiable goals so that progress can be monitored and demonstrated. But we will also promote practical, practice-level resources, guidance and measures aimed at driving positive behaviour changes and protecting patients and practitioners alike."
The academy will consist of three modules which will be launched in 2021. Those who complete all three modules will receive certification from Bimeda, and some exclusive branded goodies.
The first module is titled Bimeda Trace Elements in Dairy Cow Fertility & Pregnancy and is available now on Bimeda’s e-learning portal: https://bimeda-learning.co.uk. This module also accounts for 1 hour 15 minutes of CPD and vets can download a certificate when they complete the module. The module has also been accredited with 9 AMTRA points.
In the coming months Bimeda says it'll add a second module focused on the role of trace element nutrition in lamb and calf growth, and a final module focused on the role of trace elements in sheep fertility and pregnancy.
Bimeda UK General Manager Mark Cokayne said: "Trace elements play a critical role in the health and fertility of ruminants, yet historically this area has been somewhat overlooked in formal animal health education.
"Our customers tell us that they would like a deeper understanding of areas such as trace element deficiencies, toxicities and interactions, and the impact of these on ruminant health and fertility. We are pleased to respond to this market demand with our new academy, which will provide veterinarians and SQPs with additional knowledge to help inform their conversations with farmers."
To sign up to either Bimeda’s online Nutrition Academy or the Sheep Scab Academy, visit https://bimeda-learning.co.uk
For more information, speak to your Bimeda territory manager or call Bimeda on 01248 725 400.
Rodolfo said: “We are the only independent specialist veterinary hospital in the area with the equipment and experience to diagnose and manage neurological issues in pets.
"With a custom-built veterinary hospital and the expertise to help vets get the best results for their patients, we will provide the next level of affordable, specialist care for owners and their pets with the transparency that our independent status enables.
“We will work hand in hand with referring vets, consulting with them on the best approach for their clients and always keep them fully updated on progress as each case unfolds.
"Initially, we are offering neurology services, but we plan to quickly upscale our operations and offer other services like orthopaedics soon.”
Pets suffering from symptoms including seizures, pain, difficulty walking and problems with balance and orientation can be referred.
"Any peripheral nervous system problems and neuromuscular diseases outside the spinal cord area can also be identified and treated.
Rodolfo added: “My focus is on pure collaboration with the vets that refer to us and their owners.
"I’m wholeheartedly motivated by providing the very best service at accessible prices.
"With a focus on communication and compassion – we will always work with the first opinion vet to put the best interests of their clients’ pets first.
www.southeastvetreferrals.com
A team of three Ofsted inspectors carried out a four-day inspection, reporting that:
Head of centre Jackie Shopland-Reed said: “We are delighted to have regained our outstanding status, in our first full inspection since being graded as Good in 2015.
“It is very rewarding that the inspectors praised the high quality of teaching and the support we provide for apprentices.
"We also received feedback that apprentices enjoy their learning and feel safe and well supported.
"Our strong and effective partnerships with employers were also praised, all of which which makes us very proud.”
https://www.liteltd.co.uk
The webinar will look at what VNs can do to minimise and, in some cases, prevent surgical site infections and antibiotic resistance.
The lecture, which is presented by RVNs Rosina Lilywhite and Rosie Heath, will include discussion and top tip-sharing time.
It will also consolidate the role of the theatre nurse and provide updates on biosecurity, instrument care and how to run a theatre.
Rosina said: “We will be taking it back to basics and looking at where improvements can be made, often in areas that are so routine that we forget about their importance.
"It’s a great opportunity to see inside Liphook Equine Hospital, which is one of the largest equine hospitals in the UK and discover how to make your own set-up more gold standard.”
The course is free to BEVA Nurse members.
To register, visit https://www.beva.org.uk/Education/CPD/Event-Details/eventDateId/1707
If you are not a BEVA VN member you can join this CPD session and get a one-year BEVA membership for £49.
Photo: Safia Barakzai, Equine Surgeon
The event is merging with the new northern VETcpd Congress to give attendees a broader range of CPD subjects.
In the wound management streams, Shelly Jefferies (pictured right) will run a series of workshops on: ‘Wound preparation for optimum healing’, ‘Wound dressing selection’ and ‘Building a better bandage’.
On the first day of the lecture programme, Samantha Bell will be looking at various different aspects and considerations for wound management through all stages, from initial presentation and assessment of the traumatic wound patient, including lavage and debridement techniques, to selection of dressings for open wound management, to surgical closure.
Other speakers in the wound management stream will cover topics such as acute wound management in rabbits and other exotic species, coping with eye problems and what to do and what not to do after oral surgery to allow healing.
Alongside the wound management programme will be two streams for veterinary surgeons – open to nurses as well – with Dr David Williams (ophthalmology), Dr Bob Partridge (dentistry), Dr Molly Varga (rabbits and exotics), Dr Fergus Allerton (antibiotics and immune-mediated diseases), Professor John Innes (orthopaedics), Professor Jon Hall (small animal surgery), Dr Joanne Harris (cardiology), Dr Alison Hayes (oncology), Dr Samantha Lane small animal surgery), Dr Anita Patel (dermatology) and Angie Lloyd-Jones (ultrasound).
On day two, David Williams will conduct an interactive session on ethics in which he will present a series of cases and ask the audience to discuss what they would do in each.
There will also be a series of workshops on ultrasound, covering basic system controls and image optimisation, abdominal ultrasound assessment techniques, and other aspects.
Lastly, there will be a stream specifically for equine practitioners featuring Professor Michael Schramme of the University of Lyon, Dr Alison Talbot of the University of Liverpool, Dr Lesley Young from Newmarket, Dr Gemma Pearson from Edinburgh, David Green from the VDS and Philip Cramo of Hambleton Equine Clinic.
Accommodation is available in the Hilton Garden Inn on-site at £105 per night or £125 per night for double occupancy. This rate is available by emailing HGIreservations@doncaster-racecourse.co.uk, quoting VETcpd.
Early bird two day passes cost £195+VAT for veterinary nurses and £285+VAT for veterinary surgeons, with one day tickets also available.
www.vetcpdcongress.co.uk.